Recent developments in the management of severe asthma
Research output: Contribution to journal › Journal article › Research › peer-review
Documents
- Fulltext
Final published version, 400 KB, PDF document
Fevipiprant is unlikely to be implemented as a future treatment for severe asthma, while tezepelumab may be a future treatment option for patients with severe asthma with and without eosinophilic inflammation.
| Original language | English |
|---|---|
| Article number | 210178 |
| Journal | Breathe |
| Volume | 18 |
| Issue number | 1 |
| ISSN | 1810-6838 |
| DOIs | |
| Publication status | Published - 2022 |
ID: 327686931